/EIN News/ -- Newark, New Castle, USA, March 06, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Contrast Media Agents Market was estimated at US$ 4.8 billion in 2021 and is expected to surpass a valuation of US$ 6.37 billion by 2030, progressing at a CAGR of 3.2% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenario, wavering market trends, market size, statistics & estimations, and major investment pockets.

Download PDF Brochure of Contrast Media Agents Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.growthplusreports.com/inquiry/request-sample/contrast-media-agents-market/8280

Market Drivers

The primary factor driving the global contrast media agents market is the increasing incidence of chronic diseases, including cancer and cardiovascular disorders. Furthermore, the growing elderly population worldwide, which is more susceptible to chronic diseases, is increasing the need for diagnostic imaging procedures such as X-rays and advanced imaging technology such as MRI and CT scans. This supports the expansion of the contrast media agents market. With the rising acceptance of new contrast agents, there is a surge in R&D related to contrast agents. Therefore, the market for contrast media agents is progressing due to an increase in CT and MRI procedures and the number of new diagnostic facilities. Additionally, favorable reimbursement policies and an increase in generic contrast agents are anticipated to fuel the market growth for contrast media agents.

The global contrast media agents market has been analyzed from six perspectives: Modality, Application, Product Type, Route of Administration, End User, and Region.

Excerpts from By Modality Segmentation

Based on modalities, the global contrast media agents market is segmented in:

In the base year 2021, the market for contrast media agents is significantly dominated by the X-ray/computed tomography segment. The capacity to create non-destructive 3D images accounts for the persistently high demand for X-ray and computed tomography (CT) imaging. Additionally, because X-ray and CT imaging requires little or no specimen preparation, their use is becoming increasingly popular. In X-ray/computed tomography, iodinated and barium-based contrast fluids are commonly employed. When orally given or injected into the body, barium and iodine contrast agents function as X-ray blockers and stop the rays from going through. By temporarily containing barium- or iodinated-based contrast chemicals, images of organs, blood vessels, and other tissues are altered. The widespread use of CT and X-rays for various illnesses is expected to fuel the contrast media agents market growth.

Excerpts from By Product Type Segmentation

Based on product type, the global contrast media agents market is categorized into:

In 2021, the iodinated contrast media agents segment will command a global market revenue share. Due to its lower toxicity compared to other procedures and superior ability to produce the greatest results with the least disruption, the iodinated segment commands a dominant market share. Additionally, the nonionic stable iodinated chemicals provided by iodinated contrast agents and their excellent penetration in X-ray and CT procedures for improved diagnosis drive the segment expansion. Iodinated contrast agents are frequently utilized for several reasons, including cancer, gastrointestinal, cardiovascular, musculoskeletal, neurological, and nephrological problems. The brain, GI tract, internal organs, arteries, and veins can all be seen more clearly due to using iodinated contrast agents.

Excerpts from By Region Segmentation

Based on region, the global contrast media agents market has been segmented into:

North America dominated the global contrast media agents market in 2021, followed by Europe and Asia Pacific. The main driving factor of North America market is the presence of highly developed healthcare infrastructure and the rising demand for early disease diagnosis. Additionally, the easy accessibility to cutting-edge imaging technologies and the domicile of several major market players in the region promote North America contrast media agents market growth. Additionally, due to the consistent growth in the prevalence of chronic diseases and the growing healthcare expenditures, the Asia Pacific contrast media agents market is anticipated to grow at the fastest revenue CAGR during the forecast period from 2022 to 2030.

Request for Customization https://www.growthplusreports.com/inquiry/customization/contrast-media-agents-market/8280

Excerpts from Competitive Landscape

Some of the prominent players operating in the global contrast media agents market are:

Table of Content

TOC Continued

Contrast Media Agents Market Scope

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8280

VALUE PROPOSITIONS RELATED TO THE REPORT:

CUSTOMIZATION OPTIONS:

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse related reports:

Microarray Gene Chip Scanner Market by Type (CCD System Biochip Scanner, Laser Confocal Biochip Scanner), Application (Drug Screening, Tumor Detection) - Global Outlook & Forecast 2023-2031

Legionella Testing Market by Type (Direct Fluorescent Antibody (DFA) Testing, Culture Media, Serology, Polymerase Chain Reaction (PCR), Urine Antigen Testing) and End Users (Hospitals, Diagnostic Laboratories, Others) Global Outlook & Forecast 2023-2031

Joint Pain Injections Market by Product (Hyaluronic Acid, Corticosteroid, Platelet Rich Plasma), Joint Type (Knee & Ankle, Hip, Shoulder, Elbow), Distribution Channel (Hospitals, Retail, Online Pharmacies) - Global Outlook & Forecast 2023-2031

Hereditary Transthyretin Amyloidosis Market by Drug Class (RNAi Agents (Patisiran), Small Interfering RNAs (siRNAs)(Vutrisiran)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031

Genomics in Cancer Care Market by Product Type (Instruments, Consumables), Technology (PCR, Microarray, Genome Sequencing) Application (Diagnostics, Personalized Medicine, Drug Discovery & Development) Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

You just read:

News Provided By

March 06, 2023, 12:00 GMT

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

See the article here:
Contrast Media Agents Market Worth US$ 6.37 Billion by 2030 ... - EIN News